{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:26:15Z","timestamp":1758709575236},"reference-count":25,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.3960\/jslrt.56.130","type":"journal-article","created":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T23:04:00Z","timestamp":1481583840000},"page":"130-134","source":"Crossref","is-referenced-by-count":1,"title":["Isochromosome 17q; A Novel Finding in Myeloid Sarcoma"],"prefix":"10.3960","volume":"56","author":[{"given":"Sanjay de","family":"Mel","sequence":"first","affiliation":[{"name":"Department of Haematology, Oncology, National University Cancer Institute, National University Health System"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Haematology, Oncology, National University Cancer Institute, National University Health System"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance","family":"Chua","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, National University Health System"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sok Peng","family":"Chua","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, National University Health System"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leena","family":"Gole","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, National University Health System"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limei","family":"Poon","sequence":"additional","affiliation":[{"name":"Department of Haematology, Oncology, National University Cancer Institute, National University Health System"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, National University Health System"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siok Bian","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Te Chih","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, National University Health System"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wee Joo","family":"Chng","sequence":"additional","affiliation":[{"name":"Department of Haematology, Oncology, National University Cancer Institute, National University Health System"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen Lin","family":"Chee","sequence":"additional","affiliation":[{"name":"Department of Haematology, Oncology, National University Cancer Institute, National University Health System"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Seifert H, Mohr B, Thiede C, Oelschl\u00e4gel U, Sch\u00e4kel U, <i>et al<\/i>.: The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia. Leukemia 23:656-663, 2009","DOI":"10.1038\/leu.2008.375"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Lai JL, Preudhomme C, Zandecki M, Flactif M, Vanrumbeke M, <i>et al<\/i>.: Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoiesis and a high incidence of P53 mutations. Leukemia 9:370-381, 1995","DOI":"10.1016\/0145-2126(94)90142-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Merlat A, Lai JL, Sterkers Y, Demory JL, Bauters F, <i>et al<\/i>.: Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases. Leukemia 13:250-257, 1999","DOI":"10.1038\/sj.leu.2401298"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Pasquali F: Mechanism of origin of the isochromosome i(17q). Cancer Genet Cytogenet 80:170, 1995","DOI":"10.1016\/0165-4608(94)00173-9"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Kanagal-Shamanna R, Bueso-Ramos CE, Barkoh B, Lu G, Wang S, <i>et al<\/i>.: Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic\/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53. Cancer 118:2879-2888, 2012","DOI":"10.1002\/cncr.26537"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Lazarevi\u0107 V, Djordjevi\u0107 V, Magi\u0107 Z, Marisavljevic D, Colovi\u0107 M: Refractory anemia with ring sideroblasts associated with i(17q) and mutation of the TP53 gene. Cancer Genet Cytogenet 136:86-89, 2002","DOI":"10.1016\/S0165-4608(02)00510-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Pinheiro RF, Chauffaille Mde L, Silva MR: Isochromosome 17q in MDS: a marker of a distinct entity. Cancer Genet Cytogenet 166:189-190, 2006","DOI":"10.1016\/j.cancergencyto.2005.10.004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Testa JR, Cohen BC: Dicentric chromosome 17 in patients with leukemia. Cancer Genet Cytogenet 23:47-52, 1986","DOI":"10.1016\/0165-4608(86)90148-2"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Mertens F, Johansson B, Mitelman F: Isochromosomes in neoplasia. Genes Chromosomes Cancer 10:221-230, 1994","DOI":"10.1002\/gcc.2870100402"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 McClure RF, Dewald GW, Hoyer JD, Hanson CA: Isolated isochromosome 17q: a distinct type of mixed myeloproliferative disorder\/myelodysplastic syndrome with an aggressive clinical course. Br J Haematol 106:445-454, 1999","DOI":"10.1046\/j.1365-2141.1999.01537.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Pileri SA, Ascani S, Cox MC, Campidelli C, Bacci F, <i>et al<\/i>.: Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 21:340-350, 2007","DOI":"10.1038\/sj.leu.2404491"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Campidelli C, Agostinelli C, Stitson R, Pileri SA: Myeloid sarcoma: extramedullary manifestation of myeloid disorders. Am J Clin Pathol 132:426-437, 2009","DOI":"10.1309\/AJCP1ZA7HYZKAZHS"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Schwyzer R, Sherman GG, Cohn RJ, Poole JE, Willem P: Granulocytic sarcoma in children with acute myeloblastic leukemia and t(8;21). Med Pediatr Oncol 31:144-149, 1998","DOI":"10.1002\/(SICI)1096-911X(199809)31:3<144::AID-MPO3>3.0.CO;2-B"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Deeb G, Baer MR, Gaile DP, Sait SN, Barcos M, <i>et al<\/i>.: Genomic profiling of myeloid sarcoma by array comparative genomic hybridization. Genes Chromosomes Cancer 44:373-383, 2005","DOI":"10.1002\/gcc.20239"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Li Z, St\u00f6lzel F, Onel K, Sukhanova M, Mirza MK, <i>et al<\/i>.: Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma. Leukemia 29:2113-2116, 2015","DOI":"10.1038\/leu.2015.81"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Bettio D, Venci A, Sarina B: Near-tetraploid karyotype with an isochromosome 17q as the sole structural chromosomal rearrangement in a case of testicular granulocytic sarcoma. Cancer Genet Cytogenet 181:69-71, 2008","DOI":"10.1016\/j.cancergencyto.2007.10.022"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Fioretos T, Str\u00f6mbeck B, Sandberg T, Johansson B, Billstr\u00f6m R, <i>et al<\/i>.: Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations. Blood 94:225-232, 1999","DOI":"10.1182\/blood.V94.1.225.413k24_225_232"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Chen P, Ellmore N, Weissman BE: Functional evidence for a second tumor suppressor gene on human chromosome 17. Mol Cell Biol 14:534-542, 1994","DOI":"10.1128\/MCB.14.1.534"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Liu Y, Chen C, Xu Z, Scuoppo C, Rillahan CD, <i>et al<\/i>.: Deletions linked to TP53 loss drive cancer through p53-independent mechanisms. Nature 531:471-475, 2016","DOI":"10.1038\/nature17157"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Godfried MB, Veenstra M, v Sluis P, Boon K, v Asperen R, <i>et al<\/i>.: The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. Oncogene 21:2097-2101, 2002","DOI":"10.1038\/sj.onc.1205259"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Gutierrez C, Schiff R: HER2: biology, detection, and clinical implications. Arch Pathol Lab Med 135:55-62, 2011","DOI":"10.5858\/2010-0454-RAR.1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Chevallier P, Robillard N, Wuilleme-Toumi S, M\u00e9chinaud F, Harousseau JL, <i>et al<\/i>.: Overexpression of Her2\/neu is observed in one third of adult acute lymphoblastic leukemia patients and is associated with chemoresistance in these patients. Haematologica 89:1399-1401, 2004","DOI":"10.1182\/blood.V104.11.524.524"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Chevallier P, Robillard N, Charbonnier A, Raffoux E, Maury S, <i>et al<\/i>.: Trastuzumab for treatment of refractory\/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study. Blood 119:2474-2477, 2012","DOI":"10.1182\/blood-2011-11-390781"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Lin LI, Lin DT, Chang CJ, Lee CY, Tang JL, <i>et al<\/i>.: Marrow matrix metalloproteinases (MMPs) and tissue inhibitors of MMP in acute leukaemia: potential role of MMP-9 as a surrogate marker to monitor leukaemic status in patients with acute myelogenous leukaemia. Br J Haematol 117:835-841, 2002","DOI":"10.1046\/j.1365-2141.2002.03510.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Wang C, Chen Z, Li Z, Cen J: The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells. Leuk Res 34:1083-1090, 2010","DOI":"10.1016\/j.leukres.2010.01.016"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/56\/2\/56_130\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T23:39:36Z","timestamp":1658014776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/56\/2\/56_130\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.56.130","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}